Mesenchymal Stem/Stromal Cell Therapy Is More Cost-Effective Than Fecal Diversion for Treatment of Perianal Crohn’s Disease Fistulas

Overview of attention for article published in Frontiers in immunology, June 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 5 X users, with an upper bound of 15,984 followers.

RT @jan_nolta: Congrats to Dr. Maneesh Dave & our #Crohnsdisease team @ #UCDavis 4 this report on cost of academic GMP MSC manufacturing.…

08 Jul 2022

Reply Repost Favourite

RT @jan_nolta: Congrats to Dr. Maneesh Dave & our #Crohnsdisease team @ #UCDavis 4 this report on cost of academic GMP MSC manufacturing.…

08 Jul 2022

Reply Repost Favourite

Congrats to Dr. Maneesh Dave & our #Crohnsdisease team @ #UCDavis 4 this report on cost of academic GMP MSC manufacturing. Mesenchymal Stem/Stromal Cell Therapy Is More Cost-Effective Than Fecal Diversion for Treatment of Perianal Crohn's Disease Fist

08 Jul 2022

Reply Repost Favourite

RT @gi_jeff247: So happy to have been part of this project and to see it get out there in the world! #IBD #crohnsdisease #MSCs #GITwitter…

07 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.